Where to find DEEP this quarter

If you're rethinking how AI fits into clinical research workflows, this is the room. DEEP will be at SCOPE X showing how an AI-first approach - with Expert-in-the-Loop oversight where it matters - turns digital measures into trial-grade endpoints faster, with cleaner audit trails. Sponsors, CROs, and tech partners all welcome. We have limited slots; book early.

The European hub for clinical trial technology decision-making. DEEP's Europe team will be on the floor and in side meetings - useful if you're scoping digital measure pilots, partnering on decentralized trial tooling, or comparing platform-plus-experts models against legacy CRO setups. Sponsor, CRO, and ecosystem conversations all welcome.

The 2nd Annual Digital Breakthrough for Pharma Summit 2026 focuses on the evolving digital health landscape and the impact of novel technologies in the life sciences. DEEP US General Manager Jacqueline Thong will be speaking on a panel discussion about how pharma companies can turn digital measures into regulatory-ready evidence that accelerates development, supports approvals, and enables differentiated labeling.

Where the digital-health and AI conversations actually intersect. DEEP returns to Boston for the second time in three weeks (after SCOPE X) - a useful signal of how concentrated this conversation is right now. Stop by if you want to compare notes on how AI-first measures hold up under regulatory and clinical scrutiny.

A high-density Basel moment for biomarker-grade digital endpoints and trial-design innovation. DEEP's team is attending both days. Best for sponsors evaluating where digital measures earn regulatory and clinical credibility - and for ecosystem partners working on the next generation of trial design.